🔗 Permalink

Inventor profile of:

DAVID J. HACKAM

City:

PITTSBURGH, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2021-10-07

Top Assignees for applications by DAVID J. HACKAM

The entities that hold a legal rights for patent applications filed by inventor HACKAM DAVID J.:

UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 11 Pittsburgh, PA United States
University of Pittsburgh - of the Commonwealth System of Highter Education 2 Pittsburgh, PA United States
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH OF HIGHER EDUCATION 1 PITTSBURGH, PA United States
University of Pittsburgh Of the Commonwealth Systems of Higher Education 1 Pittsburgh, PA United States

Recent patent applications by HACKAM DAVID J.

DAVID J. HACKAM from PITTSBURGH, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-10-07

US20210308162A1

Human necessities

NOVEL TLR4 INHIBITORS FOR THE TREATMENT OF HUMAN INFECTIOUS AND INFLAMMATORY DISORDERS

#2 | 2019-12-12

US20190374562A1

Human necessities

TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

#3 | 2019-03-07

US20190070168A1

Human necessities

GAP JUNCTION-ENHANCING AGENTS FOR TREATMENT OF NECROTIZING ENTEROCOLITIS AND INFLAMMATORY BOWEL DISEASE

#4 | 2017-04-06

US20170095493A1

Human necessities

TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

#5 | 2016-10-20

US20160303229A9

Human necessities

METHODS OF TREATING NECROTIZING ENTEROCOLITIS BY ADMINISTERING NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS,TLR9 AGONISTS AND TLR4 ANTAGONISTS

#6 | 2015-09-10

US20150250809A1

Human necessities

TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

#7 | 2015-02-26

US20150056217A1

Human necessities

Methods of treating necrotizing enterocolitis by administering nuclear oligomerization domain-2 agonists,TLR9 agonists and TLR4 antagonists

#8 | 2014-03-27

US20140086982A1

Chemistry; metallurgy

Oral therapy of necrotizing enterocolitis

#9 | 2013-12-26

US20130345154A1

Human necessities

Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease

#10 | 2013-10-24

US20130281395A1

Human necessities

TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

#11 | 2013-03-21

US20130072547A1

Chemistry; metallurgy

Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disorders

#12 | 2012-03-29

US20120077868A1

Human necessities

Use of toll-like receptor-9 agonists

#13 | 2008-12-18

US20080311112A1

Chemistry; metallurgy

Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders

InventorID:

154530 ⎘